Pictet Asset Management (UK)’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | $7.97M | Buy |
35,941
+5,041
| +16% | +$1.12M | 0.01% | 738 |
|
2021
Q1 | $4.08M | Sell |
30,900
-1,300
| -4% | -$172K | ﹤0.01% | 867 |
|
2020
Q4 | $5.57M | Buy |
32,200
+25,100
| +354% | +$4.34M | 0.01% | 780 |
|
2020
Q3 | $790K | Sell |
7,100
-27,023
| -79% | -$3.01M | ﹤0.01% | 990 |
|
2020
Q2 | $2.02M | Sell |
34,123
-30,778
| -47% | -$1.82M | ﹤0.01% | 862 |
|
2020
Q1 | $4.37M | Buy |
64,901
+12,400
| +24% | +$835K | 0.01% | 675 |
|
2019
Q4 | $4.42M | Buy |
+52,501
| New | +$4.42M | 0.01% | 772 |
|